A prescription erythropoiesis-stimulating agent (ESA) containing recombinant human erythropoietin, provided in a convenient pack of 6 prefilled syringes for slow intravenous (IV) or subcutaneous (SC) injection to treat severe anemia by stimulating red blood cell production.
Epokine contains Epoetin Alfa (4000IU per 0.4ml), a purified recombinant glycoprotein that possesses the identical amino acid sequence and biological profile of natural human erythropoietin. Erythropoietin is the primary hormone naturally produced by healthy kidneys to regulate red blood cell production.
Once injected, it corrects anemia through a targeted bone marrow mechanism:
Progenitor Stem Cell Activation: It binds directly to specific erythropoietin receptors on erythroid progenitor cells located inside the bone marrow cavity.
Proliferation and Maturation: This molecular binding signals the bone marrow to accelerate the division, growth, and maturation of primitive stem cells into reticulocytes (young red blood cells).
Hemoglobin Surge: These reticulocytes enter the circulating bloodstream and mature into fully functional red blood cells within days, steadily raising hemoglobin levels, improving oxygen transport, and relieving profound systemic fatigue.
Chronic Kidney Disease Anemia: Treating symptomatic anemia in adults and pediatric patients undergoing hemodialysis, peritoneal dialysis, or those with non-dialysis chronic renal insufficiency whose kidneys no longer make enough natural erythropoietin.
Chemotherapy-Induced Anemia: Reversing severe anemia in cancer patients undergoing chemotherapy for non-myeloid malignancies to minimize the necessity for frequent blood transfusions.
Zidovudine-Induced Anemia: Supporting HIV-infected patients undergoing zidovudine therapy whose baseline endogenous erythropoietin levels are low.
Autologous Blood Donation Support: Increasing red blood cell yields in stable patients scheduled for an autologous pre-donation program prior to major elective surgeries.
Subcutaneous (SC) Injection: Injected directly into the fat layer under the skin (usually in the abdomen or thigh). This route is highly preferred for non-dialysis patients because it absorbs more slowly, allowing for lower, more economical weekly maintenance doses.
Intravenous (IV) Injection: Administered slowly over 1 to 2 minutes directly into an established IV line or a dialysis venous access port. This route is typically chosen for hemodialysis patients who already have an accessible vascular port.
Adults and pediatric patients diagnosed with laboratory-confirmed, severe anemia linked to kidney disease or active chemotherapy treatments, under the close diagnostic supervision of a nephrologist or oncologist.
Uncontrolled Hypertension: Strictly contraindicated. Epokine can cause a sharp, rapid rise in systemic blood pressure scores. Blood pressure must be fully stabilized with antihypertensive medications prior to starting therapy.
Pure Red Cell Aplasia (PRCA): Do not use if you have ever developed Pure Red Cell Aplasia (a condition where bone marrow stops producing red blood cells entirely) following treatment with any erythropoietin-based medication.
Severe Hypersensitivity: Avoid if you have a known historical allergy to mammalian cell-derived proteins, human albumin, or epoetin alfa.
The Iron Storage Law: Epokine requires a massive supply of iron to build new red blood cells. If your internal iron stores are low, the medication will fail to work properly. Your doctor will measure your ferritin and transferrin saturation levels and will frequently prescribe daily iron supplements alongside your injections.
The Target Boundary: The goal of therapy is to stabilize your hemoglobin levels within a safe, targeted clinical window (typically between 10 to 12 g/dL). Attempting to push hemoglobin levels above 12 g/dL heavily multiplies the risk of severe blood clots, stroke, heart attacks, or sudden death.
The Refrigerator Law: Store your prefilled syringes securely inside a medical refrigerator at a temperature between $2^\circ\text{C}$ to $8^\circ\text{C}$. Never freeze, shake, or expose the syringes to direct sunlight, as structural vibration and extreme temperatures permanently destroy the delicate protein molecules.
1.Bring the syringe to room temperature naturally:Thermal Stabilization.
Remove one prefilled syringe from the refrigerator box 20 to 30 minutes before application. Let it warm up naturally to room temperature to ensure a comfortable injection. Do not microwave or heat it artificially.
2.Examine the syringe and fluid clarity:Visual Inspection.
Wash your hands thoroughly. Inspect the liquid inside the 0.4ml glass barrel. Ensure it is completely clear, colorless, and free of any solid floating particles. Do not push out any tiny air bubbles unless explicitly told to do so by your nurse.
3.Pinch the skin fold and inject slowly:Tissue Delivery.
Cleanse your injection site (abdomen or thigh) with an alcohol swab. Pinch a generous fold of skin between your thumb and index finger, insert the needle straight down at a 90-degree angle, and push the plunger down steadily over several seconds.
4.Discard the needle into a sharps container:Safe Disposal.
Withdraw the needle quickly, apply gentle pressure with a clean cotton swab, but do not rub the skin site. Drop the entire used syringe assembly directly into a puncture-proof medical sharps container.
By systemically stimulating bone marrow production and increasing blood viscosity (thickness), this high-potency biological can prompt structural or systemic adjustments, including:
A sudden or progressive increase in blood pressure scores, occasionally leading to severe hypertensive crises, headaches, or confusion.
Localized pain, mild skin stinging, swelling, redness, or transient bruising directly around the subcutaneous needle insertion site.
General flu-like symptoms early in therapy, including minor joint pain, muscle aches, mild chills, or dizziness.
Serious Risk Warning: An increased risk of deep vein thrombosis (blood clots in the legs), access port clotting in dialysis patients, or severe allergic skin reactions.
How quickly can I expect my energy levels to improve after starting Epokine?
Because it takes time for your bone marrow to mature stem cells into fully functional red blood cells, you will not feel an immediate shift in physical energy after your first injection. A gradual rise in reticulocytes can typically be observed within 1 to 2 weeks, followed by a noticeable reduction in severe fatigue and shortness of breath as your hemoglobin levels climb over 4 to 6 weeks.
What should I do if my blood pressure spikes significantly at home?
Monitor your blood pressure daily. If you notice a sudden, sharp increase in your numbers, or if you develop a severe, throbbing headache or sudden dizziness, pause your next scheduled injection and contact your healthcare provider or visit an emergency room immediately. Your doctor may need to adjust your blood pressure medications or slow down your Epokine dosage progression.
Can I shake the prefilled syringe if the fluid looks slightly uneven?
Never shake an Epokine syringe. Epoetin alfa is a delicate protein molecule. Shaking the syringe vigorously can break down its molecular structure, rendering the active ingredient completely ineffective. If the fluid looks unusual or contains solid particles, do not use it and select a fresh syringe from the pack.
You can purchase genuine, factory-sealed Epokine 4000IU/0.4ml Injection (6 Prefilled Syringe pack) online through Sanlive Pharmacy & Stores for secure payment and fast, reliable cold-chain delivery directly to your hospital, clinic, or home within Lagos, Abuja, and Port Harcourt.
Important Notice: This information is for educational support and tracking purposes only. Epokine is an exceptionally high-potency, specialized biological therapy that must be calculated, prepped, and monitored strictly under the direct diagnostic guidance, blood tracking, and supervision of a certified medical professional.
No reviews yet — be the first!
Log in to write a review.